Back to Journals » Vascular Health and Risk Management » Volume 12

Review

SGLT2 inhibitors or GLP-1 receptor agonists as second-line therapy in type 2 diabetes: patient selection and perspectives

         
Total article views   Abstract views HTML views PDF downloads Totals
21,155 Dovepress* 5,370 3,270+ 2,063 8,640
PubMed Central* 0 12,515 1,980 12,515
Totals 5,370 15,785 4,043 21,155
*Since 4 June 2016
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
6 2 0 0 1 3

View citations on PubMed Central and Google Scholar